Products for Research Use Only
RegisterLogin

Fedratinib-d9

CAT: 0804-HY-10409SSize: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-10409SSize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Fedratinib-d9 (TG-101348-d9) is deuterium labeled Fedratinib. Fedratinib (TG-101348) is a potent, selective, ATP-competitive and orally active JAK2 inhibitor with IC50s of 3 nM for both JAK2 and JAK2V617F kinase. Fedratinib shows 35- and 334-fold selectivity over JAK1 and JAK3, respectively. Fedratinib induces cancer cell apoptosis and has the potential for myeloproliferative disorders research[1][2][3].
Product Name Alternative
TG-101348-d9; SAR 302503-d9
UNSPSC
12352005
Target
Apoptosis; Isotope-Labeled Compounds; JAK
Type
Isotope-Labeled Compounds
Related Pathways
Apoptosis; Epigenetics; JAK/STAT Signaling; Others; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O=S(C1=CC=CC(NC2=NC(NC3=CC=C(OCCN4CCCC4)C=C3)=NC=C2C)=C1)(NC(C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])=O
Molecular Formula
C27H27D9N6O3S
Molecular Weight
533.73
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.|[2]Geron I, et al. Selective inhibition of JAK2-driven erythroid differentiation of polycythemia vera progenitors. Cancer Cell. 2008 Apr;13 (4) :321-30.|[3]Wernig G, et al. Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera. Cancer Cell. 2008 Apr;13 (4) :311-20.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-10409-01Fedratinib
HY-10409R-01Fedratinib (Standard)
HY-10409A-01Fedratinib (hydrochloride hydrate)
HY-10409AR-01Fedratinib (hydrochloride hydrate) (Standard)
HY-B1355AS-01Oxyphenbutazone-d9
HY-B1431S2Butylparaben-d9
HY-B0552SDibucaine-d9
HY-17007SSaquinavir-d9
HY-131105S-01Cimbuterol-d9
HY-127035S4-01Tristearin-d9

Alternative Products

CatalogName
FD151499-01Fedratinib
CS-O-44789Fedratinib-d8
C08814-5mgFedratinib (TG101348)
CS-O-44790Fedratinib-d4
A9916-100Fedratinib hydrochloride hydrate
AR-F09859-01Fedratinib Impurity 3
AR-F09858-01Fedratinib Impurity 2
564142Fedratinib HCl hydrate

Popular Products